ROMMEL GO: Open Payments
NPI 1477548469 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 35 payments from 16 companies in 2025. Trend: 2023 $2,296 · 2024 $1,340 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 5 | $268 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 1 | $81 |
| Exact Sciences Corporation | 5 | $73 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Gilead Sciences, Inc. | 2 | $36 |
| Indivior Inc. | 1 | $29 |
| Braeburn Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
Products named: RECORLEV, AIRSUPRA, Kerendia, FANAPT, VERQUVO, Cologuard Collection Kit, SUBLOCADE, BREZTRI.
Industry payments across AL — which companies pay providers there.
